The circadian clock and the hypoxic response pathway in kidney cancer

被引:18
作者
Mazzoccoli, Gianluigi [1 ,2 ]
De Cata, Angelo [1 ,2 ]
Piepoli, Ada [3 ,4 ]
Vinciguerra, Manlio [1 ,2 ,5 ,6 ]
机构
[1] IRCCS Sci Inst & Reg Gen Hosp Casa Sollievo Soffe, Div Internal Med, Dept Med Sci, San Giovanni Rotondo, FG, Italy
[2] IRCCS Sci Inst & Reg Gen Hosp Casa Sollievo Soffe, Chronobiol Unit, San Giovanni Rotondo, FG, Italy
[3] IRCCS Sci Inst & Reg Gen Hosp Casa Sollievo Soffe, Dept Med Sci, Res Lab, San Giovanni Rotondo, Italy
[4] IRCCS Sci Inst & Reg Gen Hosp Casa Sollievo Soffe, Div Gastroenterol Unit, San Giovanni Rotondo, Italy
[5] Ist EuroMEditerraneo Sci Tecnol, Palermo, Italy
[6] UCL, Div Med, Inst Liver & Digest Hlth, London, England
关键词
Kidney; Cancer; Clock gene; Circadian; Rhythm; Hypoxia; RENAL-CELL CARCINOMA; PLASMINOGEN-ACTIVATOR INHIBITOR-1; ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION LEVELS; TUMOR-SUPPRESSOR GENE; REV-ERB-ALPHA; TRANSCRIPTIONAL ACTIVATION; REGULATOR; MACHINERY; PTEN;
D O I
10.1007/s13277-013-1076-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The most frequent malignant tumor of the kidney in adults is represented by renal cell carcinoma characterized by high lethality related to presence of metastatic disease at the time of diagnosis. The main characteristic molecular feature of most sporadic renal cell carcinomas is the mutation of the tumor suppressor gene encoding the von Hippel-Lindau protein, with alteration of regulated pathways and activation of hypoxia-inducible transcription factors. Hypoxia-inducible transcription factors are transcriptional regulators of genes controlling mammalian oxygen homeostasis, energy metabolism, neovascularisation, internal pH, cell survival, and migration and are considered powerful promoters of tumor growth. Tight interrelationships have been evidenced between hypoxic response pathway and circadian pathway. Severe deregulation of genes involved in the circadian clock circuitry and response to hypoxia has been found in patients affected by kidney cancer, influencing the process of carcinogenesis, as well as disease progression and outcome. The study of alterations of clock gene expression and hypoxia correlated pathway in kidney cancer may promote the comprehension of pathophysiological mechanisms involved in renal cell carcinoma onset and evolution and may help to exploit more effective therapeutic approaches.
引用
收藏
页码:1 / 7
页数:7
相关论文
共 59 条
[1]   Casein Kinase-1-Epsilon (CK1) and Circadian Photic Responses in Hamsters [J].
Agostino, Patricia V. ;
Harrington, Mary E. ;
Ralph, Martin R. ;
Golombek, Diego A. .
CHRONOBIOLOGY INTERNATIONAL, 2009, 26 (01) :126-133
[2]   Point mutation and homozygous deletion of PTEN/MMAC1 in primary bladder cancers [J].
Cairns, P ;
Evron, E ;
Okami, K ;
Halachmi, N ;
Esteller, M ;
Herman, JG ;
Bose, S ;
Wang, SI ;
Parsons, R ;
Sidransky, D .
ONCOGENE, 1998, 16 (24) :3215-3218
[3]   Tumor suppression and circadian function [J].
Chen-Goodspeed, Misty ;
Lee, Cheng Chi .
JOURNAL OF BIOLOGICAL RHYTHMS, 2007, 22 (04) :291-298
[4]   Hypoxia affects expression of circadian genes PER1 and CLOCK in mouse brain [J].
Chilov, D ;
Hofer, T ;
Bauer, C ;
Wenger, RH ;
Gassmann, M .
FASEB JOURNAL, 2001, 15 (14) :2613-2622
[5]   Regulation of circadian behaviour and metabolism by REV-ERB-α and REV-ERB-β [J].
Cho, Han ;
Zhao, Xuan ;
Hatori, Megumi ;
Yu, Ruth T. ;
Barish, Grant D. ;
Lam, Michael T. ;
Chong, Ling-Wa ;
DiTacchio, Luciano ;
Atkins, Annette R. ;
Glass, Christopher K. ;
Liddle, Christopher ;
Auwerx, Johan ;
Downes, Michael ;
Panda, Satchidananda ;
Evans, Ronald M. .
NATURE, 2012, 485 (7396) :123-127
[6]  
Contractor H, 1997, J PATHOL, V181, P136, DOI 10.1002/(SICI)1096-9896(199702)181:2<136::AID-PATH766>3.0.CO
[7]  
2-2
[8]   Mining Tissue Microarray Data to Uncover Combinations of Biomarker Expression Patterns that Improve Intermediate Staging and Grading of Clear Cell Renal Cell Cancer [J].
Dahinden, Corinne ;
Ingold, Barbara ;
Wild, Peter ;
Boysen, Gunther ;
Luu, Van-Duc ;
Montani, Matteo ;
Kristiansen, Glen ;
Sulser, Tullio ;
Buehlmann, Peter ;
Moch, Holger ;
Schraml, Peter .
CLINICAL CANCER RESEARCH, 2010, 16 (01) :88-98
[9]   PI3K/Akt Signalling Pathway Specific Inhibitors: A Novel Strategy to Sensitize Cancer Cells to Anti-Cancer Drugs [J].
Falasca, Marco .
CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (12) :1410-1416
[10]  
Fallone F, 2012, ONCOGENE, DOI [10.1038/onc.2012.462, DOI 10.1038/0NC.2012.462]